Stillwater Investment Management (Minnesota)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$766K Hold
9,622
0.21% 57
2022
Q4
$651K Hold
9,622
0.18% 58
2022
Q3
$479K Buy
9,622
+36
+0.4% +$1.93K 0.15% 60
2022
Q2
$534K Buy
9,586
+60
+0.6% +$3.33K 0.16% 61
2022
Q1
$529K Hold
9,526
0.13% 61
2021
Q4
$533K Hold
9,526
0.13% 61
2021
Q3
$457K Buy
9,526
+36
+0.4% +$1.74K 0.12% 64
2021
Q2
$397K Buy
9,490
+90
+1% +$3.49K 0.11% 68
2021
Q1
$317K Hold
9,400
0.09% 68
2020
Q4
$328K Buy
+9,400
New +$325K 0.1% 67

Other funds holding NVO

Stillwater Investment Management (Minnesota)'s NVO Position: Q1 2023 in Review

Stillwater Investment Management (Minnesota) held its Novo Nordisk (NVO) position steady in Q1 2023 at 9,622 shares worth $766K. The position accounts for 0.21% of the portfolio, ranked #57.

Stillwater Investment Management (Minnesota) first reported a position in NVO in Q4 2020 and has held it in 10 quarters since. 1,147 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • Stillwater Investment Management (Minnesota) held 9,622 shares of Novo Nordisk worth $766K as of Q1 2023.
  • Stillwater Investment Management (Minnesota) left its Novo Nordisk share count unchanged in Q1 2023.
  • Novo Nordisk made up 0.21% of Stillwater Investment Management (Minnesota)'s portfolio in Q1 2023, its #57 holding.
  • Stillwater Investment Management (Minnesota) first reported a position in Novo Nordisk in Q4 2020 and has held it in 10 quarters since.
  • 1,147 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on Stillwater Investment Management (Minnesota)'s 13F filing for Q1 2023, filed 5 Apr 2023.